Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioSig Technologies, Inc. - Common Stock (NQ:BSGM)

8.320 +1.180 (+16.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about BioSig Technologies, Inc. - Common Stock

< Previous 1 2 3 Next >
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
32-year career in medical device and electrophysiology business expansion for industry bellwethers; led multiple company exits including a $1B sale in 2018 Part of leadership team that grew Johnson &... 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
PURE EP™ subscriber community now includes two of top three U.S. health systems in cardiology: Mayo Clinic-Phoenix and Cleveland Clinic 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI
IP portfolio includes U.S. and worldwide utility and design patents and pending applications in the U.S., Europe, and Asia-Pacific 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
Cleveland Clinic, the #1 heart center in the Nation, signs on as first subscriber to receive latest software advancements in intracardiac signal visualization 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
Latest Software Release Supports Electrophysiologists with Visualizing Heart Patterns Difficult to Recognize with the Naked Eye 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
Deal to create additional value through subsidiary to advance Artificial Intelligence strategy without dilution to BioSig Technologies Shareholders 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Joins Webull Corporate Connect
Webull’s investor community can now access real-time BioSig investor communications and Q&A 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare
From BioSig Technologies, Inc.
Via GlobeNewswire
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
Via ACCESSWIRE
New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP™ Platform 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Announces New Advisory Board Member Edwin Wang
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Announces New Advisory Board Member Lorraine Spurge
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Confirms No Exposure to Silicon Valley Bank
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Regains Compliance With All Nasdaq Listing Standards
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Awarded US Patent Claims for its Universal Notch Filter Technology
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology
From BioSig Technologies, Inc.
Via GlobeNewswire
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference 
From BioSig Technologies, Inc.
Via GlobeNewswire
Global Cardiac Arrhythmia Monitoring Devices Market Size Expected to Reach $11.4 Billion by 2030
Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart.... 
Via FinancialNewsMedia
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
Clinical abstract focuses on value of PURE EP™’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress 
From BioSig Technologies, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.